# FDA Inspection 1163185 - CSL Plasma Inc. - February 09, 2022

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/bd58a0ec-d49f-4e05-affc-22685f735969
Source feed: FDA_Inspections

> FDA Inspection 1163185 for CSL Plasma Inc. on February 09, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1163185
- Company Name: CSL Plasma Inc.
- Inspection Date: 2022-02-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1163185 - 2022-02-09](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/b47ba514-8e5c-46fe-86e5-85ad0f85d205)
- [FDA Inspection 1052860 - 2018-04-25](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/096fbae0-f7f6-4b25-9a2c-4c71f6a5fc0e)
- [FDA Inspection 987765 - 2016-09-16](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/c565c860-3d48-45b4-9571-45606a614d79)

Company: https://www.keypedia.com/companies/csl-plasma-inc/80f08248-fd7a-45f8-8d3a-9c31ebddc8fa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d